Edward J. Merino,James Mulloy,Anish K. Vadukoot,Mark Wunderlich,Safnas F. Abdulsalam
申请号：
US15026442
公开号：
US20160318849A1
申请日:
2015.10.02
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Provided are compounds according to the following Formula I:The Formula I compounds are activated in the presence of hydrogen peroxide and are therefore selective anti-cancer therapeutics for cancers associated with elevated reactive oxygen species (ROS). Also provided are methods and pharmaceutical compositions for treating cancers associated with increased ROS.
